1397691-96-1

Basic information

• Product Name: 2-(5-amino-6-benzyl-3-chloropyrazin-2-yl)-5-methoxybenzaldehyde
• Synonyms: 2-(5-amino-6-benzyl-3-chloropyrazin-2-yl)-5-methoxybenzaldehyde
• CAS NO: 1397691-96-1
• Molecular Weight: 353.808
• Mol File: 1397691-96-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-(5-amino-6-benzyl-3-chloropyrazin-2-yl)-5-methoxybenzaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(5-amino-6-benzyl-3-chloropyrazin-2-yl)-5-methoxybenzaldehyde(1397691-96-1)
• EPA Substance Registry System: 2-(5-amino-6-benzyl-3-chloropyrazin-2-yl)-5-methoxybenzaldehyde(1397691-96-1)

Safety Data

• Hazardous Substances Data: 1397691-96-1(Hazardous Substances Data)

Upstream product

• 1397691-95-0 2-amino-3-benzyl-5-bromo-6-chloropyrazine 
• 139962-95-1 2-formyl-4-methoxyphenylboronic acid 

Downstream Products

• 1397691-97-2 2-(5-amino-6-benzyl-3-vinylpyrazin-2-yl)-5-methoxybenzaldehyde 
• 1397691-98-3 2-amino-3-benzyl-5-(4-methoxy-2-vinylphenyl)-6-vinylpyrazine 
• 1397691-99-4 N-(3-benzyl-5-(4-methoxy-2-vinylphenyl)-6-vinylpyrazin-2-yl)acetamide 
• 1397692-00-0 N-(2-benzyl-8-methoxybenzo[f]quinoxalin-3-yl)acetamide 
• 1397692-02-2 N-(2-benzyl-8-hydroxybenzo[f]quinoxalin-3-yl)acetamide 
• 1397692-03-3 3-amino-2-benzylbenzo[f]quinoxalin-8-ol (14,v-coelenteramine) 
• 114496-03-6 12-benzyl-8-hydroxy-2-(4-hydroxybenzyl)-11H-benz[f]imidazo[1,2-a]quinoxalin-3-one 
• 1397692-04-4 12-benzyl-8-hydroxy-2-[4-(trifluoromethyl)benzyl]-11H-benz[f]imidazo[1,2-a]quinoxalin-3-one 

Relevant articles and documents

Concise Synthesis of v-Coelenterazines

A novel synthetic method for v-coelenterazine (v-CTZ), which is a vinylene-bridged analog of native CTZ with a large red-shifted luminescence property, is described. The synthesis was achieved in a concise way through the use of three sequential cross-cou

PROCESS FOR PRODUCING v-COELENTERAZINE COMPOUNDS

A simple process for producing v-coelenterazine compounds has been desired. Described is a process for producing a v-coelenterazine compound represented by general formula (II) comprising (1) the step of reacting a compound of general formula (VIII) with a methyltriphenylphosphonium salt in the presence of a base to give a compound represented by general formula (IX), (2) the step of performing a ring-closing metathesis reaction on any one selected from the group consisting of the compound represented by general formula (IX) and a compound of general formula (X) which is the compound of general formula (IX) wherein the amino is protected with R5, and then deprotecting R4 and, if any, R5 to give a v-coelenteramine compound represented by general formula (XIV), and (3) the step of reacting the compound of general formula (XIV) with a compound represented by general formula (XV) to give the compound of general formula (II).